Walleye Trading
KURA icon

Walleye Trading’s Kura Oncology KURA Stock Holding History

Walleye Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,300
Closed -$107K – 4428
2025
Q4 		$107K Buy
+10,300
New +$108K ﹤0.01% 3705
2024
Q3 		– Sell
-4,500
Closed -$92.7K – 4368
2024
Q2 		$92.7K Buy
4,500
+100
+2% +$2.06K ﹤0.01% 3398
2024
Q1 		$93.9K Buy
+4,400
New +$85.5K ﹤0.01% 3801
2021
Q1 		– Sell
-100
Closed -$3K – 5056
2020
Q4 		$3K Buy
+100
New +$3.51K ﹤0.01% 4508

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's KURA Position: Q1 2026 in Review

Walleye Trading sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 7,055 shares — an estimated $73.3K sold.

Walleye Trading first reported a position in KURA in Q1 2018 and held it in 7 quarters. The position peaked at $2.25M in Q2 2018. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Walleye Trading reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 7,055 Kura Oncology shares in Q1 2026, an estimated $73.3K.
  • Walleye Trading first reported a position in Kura Oncology in Q1 2018 and held it in 7 quarters.
  • Walleye Trading's Kura Oncology position peaked at $2.25M in Q2 2018.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.